Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aliskiren and Amlodipine vs Ramipril in Elderly Hypertension
NCT01922141Phase 4Withdrawn
- Sponsor
- Novartis
- Start
- May 2015
- Primary completion
- Jun 2018
- Modality
- Small Molecules
01
Overview
A Phase 4 trial of aliskiren in hypertension (HTN), sponsored by Novartis. Planned start May 2015; status: withdrawn.
02
Drugs
aliskiren
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT01922141.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01922141.